Correlation Between Capacite Infraprojects and Aarey Drugs

Can any of the company-specific risk be diversified away by investing in both Capacite Infraprojects and Aarey Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capacite Infraprojects and Aarey Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Capacite Infraprojects Limited and Aarey Drugs Pharmaceuticals, you can compare the effects of market volatilities on Capacite Infraprojects and Aarey Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capacite Infraprojects with a short position of Aarey Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capacite Infraprojects and Aarey Drugs.

Diversification Opportunities for Capacite Infraprojects and Aarey Drugs

-0.17

Correlation Coefficient

Capacite Infraprojects  Aarey Drugs

Good diversification

The 3 months correlation between Capacite and Aarey is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Capacite Infraprojects Limited and Aarey Drugs Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarey Drugs Pharmace and Capacite Infraprojects is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capacite Infraprojects Limited are associated (or correlated) with Aarey Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarey Drugs Pharmace has no effect on the direction of Capacite Infraprojects i.e., Capacite Infraprojects and Aarey Drugs go up and down completely randomly.

Pair Corralation between Capacite Infraprojects and Aarey Drugs

Assuming the 90 days trading horizon Capacite Infraprojects Limited is expected to generate 1.25 times more return on investment than Aarey Drugs. However, Capacite Infraprojects is 1.25 times more volatile than Aarey Drugs Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Aarey Drugs Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  39,435  in Capacite Infraprojects Limited on October 10, 2024 and sell it today you would earn a total of  3,610  from holding Capacite Infraprojects Limited or generate 9.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Capacite Infraprojects Limited  vs.  Aarey Drugs Pharmaceuticals

Capacite Infraprojects

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Capacite Infraprojects Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain forward indicators, Capacite Infraprojects may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Aarey Drugs Pharmace

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Aarey Drugs is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Capacite Infraprojects and Aarey Drugs

The main advantage of trading using opposite Capacite Infraprojects and Aarey Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capacite Infraprojects position performs unexpectedly, Aarey Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarey Drugs will offset losses from the drop in Aarey Drugs' long position.

The idea behind Capacite Infraprojects Limited and Aarey Drugs Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.